Navigation Links
Med in Medical Technology

Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition

Varian to showcase products ranging from treatment planning software for radiation therapy to flat panel detectors for filmless X-ray imaging BEIJING, March 16 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR ) will showcase the full spectrum of the company's cancer treatme...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... The epidemiology of HIV coreceptor tropism. Eur J med Res (2007) 12: 385-390. 2 Atazanavir sulfate ...py and the risk of myocardial infarction. N Engl J med 2003; 349: 1993-2003. 6 The DAD study group. C...gs and the risk of myocardial infarction. N Engl J med 2007; 356: 1723-35. 7 The DAD study group. Use...

SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts

...York, NY Mitchell Schare, PhD Program Director, Department of Clinical Psychology, Hofstra University , Hempstead, NY Mary E. Wilfert, med Associate Director of Health and Safety, National Collegiate Athletic Association, Indianapolis, IN Bruce Goldberger, PhD Professor and Di...

Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)

...2005 by STD Med, Inc., a Stoughton-based manufacturer and developer of medical technologies. In addition to Spirus, other companies that began at STD med are Angiolink Corporation, Arthrosurface Incorporated, and Cardiosolutions, Inc. For more on Spirus Medical, visit www.spirusmed.com ...

Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development

...ation is available at www.barrx.com . About the New England Journal of Medicine The New England Journal of Medicine (N Engl J med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular an...

New NIH-Funded Study Shows Masimo Rainbow SET(R) May Help Clinicians Assess Oxygenation in Children With Sickle Cell Disease

...en, J.L. "Non-Invasive Measurements of Carboxyhemoglobin and Methemoglobin in Pediatric Patients with Sickle Cell Disease." Am. J. Respir. Crit. Care med ., Apr 2009; 179: A4788. Presented at the American Thoracic Society (ATS) Annual Meeting, May 19, 2009, San Diego, California. http://www.abstracts2...

Study Reported Tadalafil Taken Once Daily Improved Erectile Function in Men with ED and Sexual Quality of Life in Couples

...ctile Dysfunction, http://kidney.niddk.nih.gov/kudiseases/pubs/impotence/ . Data accessed 09/28/07. (7) Lue, Tom F. Erectile Dysfunction. N Engl J med 2000; 342: 1802-1813. (Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO ) ...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

...lopidogrel and prasugrel based on genetic variations. The main TRITON-TIMI 38 clinical trial, previously published in the New England Journal of med i cine in November 2007 (Vol. 357 No.20), compared prasugrel with clopidogrel in patients with ACS undergoing PCI. In the primary analysis of the s...

First Human Study to Show 'Sun Chlorella A' Supports Heart Health

...ki, "Nutrigenomic Studies of Effects of Chlorella on Subjects with High-Risk Factors for Lifestyle-Related Diseases", JOURNAL OF MEDICINAL FOOD, J med Food 11 (3) 2008, 395-404 Janet Poveromo, Aiming for the Heart to Target Cardiovascular Health Specifically Ingredient Companies are Broadening ...

Congressional 'Sting' Operation Uncovered By Coast IRB

...2009, Coast IRB, an Independent review board, discovered that a protocol submitted to it for review of a medical device called Adhesiabloc by a Device med Systems of Clifton, Virginia, was in fact fraudulent in violation of federal and state law. Upon receipt of proof of the fraud, Coast IRB and its CEO...

Diabetes Patients with High Triglycerides and Low HDL Cholesterol Get the Most Benefit From Fenofibrate Treatment: New Data From the FIELD Study

...o AM, LaRosa JC et al, Treating to New Targets Investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J med 2007; 357: 1301-10. 4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholest...

Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa

...fety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J med 2008;359:2533-44. (2) Bejon P, Lusingu J, Olotu A, et al. Efficacy of RTS,S/AS01E: clinical malaria in 5 to 17 month old children. N Engl J med 2008;359: (3) World Health Organization. World Malaria Report 2008,...

Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting

...h FC Alone: Final Results F r om the International Randomi z ed Phas e III R E AC H Trial [LB A -1] Tadeusz Robak, M.D., Ph.D., med i cal Universit y , Lodz, Poland *Abstract LBA-1 is being presented on Saturday, December 6, at 2:00 p.m. at the ASH press conference on...

Roche and FDA Agree on Pathway Towards U.S. Approval of ACTEMRA(R) (tocilizumab)

... treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a...

Siemens Introduces New Standard of Care for Breast Ultrasound

...g (promo code: Siemens). (1) 510 (k) pending; not available in the United States (2) Not available in the United States (3) N Engl J med 356;3. Boyd N.F. et Al., Mammographic Density and the Risk and Detection of Breast Cancer (4) Radiology 2002;225:165-175. Kolb T.M. et Al., Compar...

CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients

...nts Arch Dermatol Res (2006) 5. Paller, AS et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J med 2008;358:241-51 ...

Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease

... chief cause of persistent or recurrent symptoms.(1) (1) Green, P, and Cellier, C, Review Article, Medical Progress, Celiac Disease, N ENGL J med 2007;357:1731-43 About "Larazotide Acetate" Larazotide acetate is an experimental medicine and a tight junction regulator that acts locally by inh...

Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients

...tion antiretroviral therapy and the risk of myocardial infarction. N Engl J med 2003; 349: 1993-2003. (9) The DAD study group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J med 2007; 356: 1723-35. (10) The DAD study group. Use of nucleoside reverse t...

New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Diamyd(R) Study Published in Prestigious New England Journal of Medicine

...troduction of Diamyd(R)." About the article: "GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes" J Ludvigsson et al., N Engl J med 2008;359 (Epub ahead of print 10.1056/NEJMoa0804328) About Diamyd(R) Type 1: Diamyd(R) Type 1 is the treatment of recently diagnosed patients with...

TRANSCEND(TM) Trial Results Presented at European Society of Cardiology Congress and Published in The Lancet

...diovascular events in high-risk patients. N Engl J med 2000; 342:145-53. (3) The ONTARGET investigators...patients at high risk for vascular events. N Eng J med 2008; 358(15):1547-59. (4) Israili ZH, Hall WD. ... of the literature and pathophysiology. Ann Intern med 1992; 117(3):234-42. (5) Matchar DB, et al. Syst...

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

..., Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension: Results from a national prospective registry. Ann Intern med 1991; 115: 343-349. 6. Barst RJ, McGoon M, Torbicki A et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll ...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

.... Vascular and cardiac benefits of angiotensin receptor blockers. Am J med 2002;113:409-18. 6. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correct...ar outcomes in patients with type 2 diabetes and nephropathy. N Engl J med 2001;345:861-9. 17. Dahlof B, Pennert K, Hansson L. Reversal of left ventr...

Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis

...JAMA. 2005;293:1653-1662. (3) Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J med .1995; 333:1253-1258. (4) Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:369...

ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference

... and Cellier, C, Review Article, Medical Progress, Celiac Disease, N ENGL J med 2007;357:1731-43 (3) Green, P, and Cellier, C, Review Article, Medical Progress, Celiac Disease, N ENGL J med 2007;357:1731-43 ...

Amikacin Inhale Shows Promising Results in Phase II Study

...t the Internet links provided) is intended to be incorporated by reference in this press release. (1) Chastre J & Fagon J-Y. Am J Respir Crit Care med 2002;165:867-903 (2) Corkery K, et al. Evidence of High Amikacin Lung Deposition in Mechanically Ventilated Patients (MVP) with Pneumonia and He...

PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab)

...her2&dictionary =. Accessed May 7, 2008. 3. Geyer C, et. al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J med 2006;355:2733-43. ...

Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations

...ensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern med 2003; 163: 525-41 (13) Mancia G, et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arter...

CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date

... Munoz N, Bosch FX, de Sanjose S,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J med 2003; 348: 518-527 (15) Munoz N, Bosch FX, Castellsague X et al. Against which human papillomavirus types shall we vaccinate and screen? The int...

New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events

...uture events or otherwise. (*) Lieberman JA, et al. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. N Engl J med 2005 Sep 22;353(12):1209-23. (1) Positive and Negative Symptom Scale Total (PANSS-T) (2) PANSS Negative (PANSS-N), PANSS Positive (PANSS-P) (3) Br...

Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing

...d treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2007 Roche was named Top Company of the Year by med Ad News, one of the Top 20 Employers (Science) and ranked the No. 1 Company to Sell For (Selling Power). In previous years, Roche has been named as a ...

Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients

... The epidemiology of HIV coreceptor tropism. Eur J med Res (2007) 12: 385-390. 2 Atazanavir sulfate i...and the risk of myocardial infarction. N Engl J med 2003; 349: 1993-2003. 8 The DAD study group. Clas...and the risk of myocardial infarction. N Engl J med 2007; 356: 1723-35. 9 The DAD study group. Use of...
Other Tags
(Date:3/5/2015)... 5, 2015 In Brazil , ... already using these solutions and 42 percent planning to invest ... approximately 25 percent of the companies will be investing in ... majority of companies in the region are currently opting for ... model will command significant attention in the coming years. This ...
(Date:3/2/2015)... March 2, 2015 Synaptics Inc. (NASDAQ: ... human interface solutions, today announced a new implementation ... to enable rapid and secure transactions and reliable ... gaming is a turnkey solution providing mouse and ... quickly integrate fingerprint ID solutions into their product ...
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial Services ... in the Health and Fitness Industry, today announced ... to MYiCLUBonline.  The latest upgrade includes advances to ... of cardless check-in via Identity One fingerprint biometrics. ... time through interactive displays at the International Health, ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3
(Date:3/27/2015)... 2015 Top medical tourism firm, ... to the Dominican Republic to benefit from the experience ... turning the medical tourism industry upside-down and becoming a ... trustworthy services becoming the central influence. , “Trust ... Patients are not only attracted to low-cost surgical enhancement, ...
(Date:3/27/2015)... San Jose, CA (PRWEB) March 27, 2015 ... last week’s 2015 GPU technology conference (GTC) , the ... to fight cancer and push the human lifespan well beyond ... Baltimore MD informatics company , is one of 12 ... , While other startups in the GTC Emerging ...
(Date:3/27/2015)... 27, 2015 Endure Yoga is launching ... fitness athletes. This new program matches yoga poses with ... post-workout cool down. This program utilizes yoga to improve ... mental focus. , Karen Lefurgy, competitive athlete at ... long before I started Crossfit® training, but quickly, due ...
(Date:3/27/2015)... GrassrootsHealth, an international nonprofit public health promotion ... vitamin D demonstration project April 7 in the Charleston ... and will soon follow with a second phase in ... a minimum of 500 pregnant women at 17 weeks ... areas. The project will include patient and health care ...
(Date:3/27/2015)... Georgia (PRWEB) March 27, 2015 To address ... shade issues, Super-Sod spent a year filming this video to ... needs and the shady environment it's often expected to thrive ... , All plants need light to survive. Anytime a sun-loving ... being put on a diet. Many homeowners try to amend ...
Breaking Medicine News(10 mins):Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 2Health News:Dominican Republic Plastic Surgery Provider Turning Medical Tourism Upside-Down 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
Other Contents